1. Home
  2. ILMN vs ARES Comparison

ILMN vs ARES Comparison

Compare ILMN & ARES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • ARES
  • Stock Information
  • Founded
  • ILMN 1998
  • ARES 1997
  • Country
  • ILMN United States
  • ARES United States
  • Employees
  • ILMN N/A
  • ARES N/A
  • Industry
  • ILMN Medical Specialities
  • ARES Investment Managers
  • Sector
  • ILMN Health Care
  • ARES Finance
  • Exchange
  • ILMN Nasdaq
  • ARES Nasdaq
  • Market Cap
  • ILMN 23.6B
  • ARES 35.1B
  • IPO Year
  • ILMN 2000
  • ARES 2014
  • Fundamental
  • Price
  • ILMN $143.87
  • ARES $182.40
  • Analyst Decision
  • ILMN Buy
  • ARES Buy
  • Analyst Count
  • ILMN 19
  • ARES 14
  • Target Price
  • ILMN $162.67
  • ARES $166.77
  • AVG Volume (30 Days)
  • ILMN 2.0M
  • ARES 1.1M
  • Earning Date
  • ILMN 02-06-2025
  • ARES 02-06-2025
  • Dividend Yield
  • ILMN N/A
  • ARES 2.04%
  • EPS Growth
  • ILMN N/A
  • ARES 0.39
  • EPS
  • ILMN N/A
  • ARES 2.19
  • Revenue
  • ILMN $4,390,000,000.00
  • ARES $3,679,765,000.00
  • Revenue This Year
  • ILMN N/A
  • ARES $0.31
  • Revenue Next Year
  • ILMN $4.28
  • ARES $33.19
  • P/E Ratio
  • ILMN N/A
  • ARES $83.48
  • Revenue Growth
  • ILMN N/A
  • ARES 4.67
  • 52 Week Low
  • ILMN $97.36
  • ARES $112.83
  • 52 Week High
  • ILMN $156.66
  • ARES $185.06
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 50.48
  • ARES 65.35
  • Support Level
  • ILMN $140.67
  • ARES $174.48
  • Resistance Level
  • ILMN $151.75
  • ARES $180.33
  • Average True Range (ATR)
  • ILMN 4.76
  • ARES 3.80
  • MACD
  • ILMN 0.47
  • ARES 0.38
  • Stochastic Oscillator
  • ILMN 38.77
  • ARES 76.50

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About ARES Ares Management Corporation

Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets and Secondaries Group. Its Credit Group generates maximum revenue, and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate and infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure and credit.

Share on Social Networks: